Corrections

October 14, 1992

An item in the Business section Oct. 6 incorrectly identified the university that licensed to DNX Inc. a new technology that could be used to develop a blood substitute. The University of Maryland at Baltimore sold the rights to the Princeton, N.J., company.

The Sun regrets the errors.

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.